Back to Agenda
SESSION 1: DRUG DEVELOPMENT
Session Chair(s)
Patricia Fitzgerald, PhD
Chief Executive Officer
ADAMAS Consulting Group Ltd, United Kingdom
Drug Development Overview| Clinical Development Phases| Product Life Cycle
Speaker(s)
DRUG DEVELOPMENT
Jennifer A Kealy, MPH
Swiss Tropical and Public Health Institute, Switzerland
Head, Quality Management Services, Medicines Research Department
Have an account?
Ways to register
Registration fee includes refreshment breaks, lunch on the 1st day of the course and training course material.
For bank transfer payment please use the printable registration form which is available at the back of the programme (click on View PDF below).
This course has limited capacity. Register early!